About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
ISSN 2073–4034
eISSN 2414–9128
About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
Logout
Year
2025202420232022202120202019201820172016201520142012201120102009200820072006200520042003200220012000
Edition number
№20 (273)№19 (272)№18 (271)№17 (270)№s5-13№15 (268)№s4-13№s3-13№14 (267)№13 (266)№12 (265)№11 (264)№10 (263)№9 (262)№s2-13№5 (258)№8 (261)№7 (260)№6 (259)№4 (257)№3 (256)№2 (255)№s1-13№1 (254)

№16 (269) / 2013

E.V. Biryukova, T.B. Danilova
EFFICACY AND SAFETY OF GLYCAEMIC CONTROL USING DIABETON MR: PREREQUISITE FOR SUCCESSFUL PREVENTION OF CHRONIC COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
14-16
I.A. Kurnikova
METABOLIC SYNDROME IN DIABETIC PATIENTS AND ITS CORRECTION USING THIOCTIC ACID PREPARATIONS
20-26
N.A. Chernikova 1, M.B. Antsiferov 2
ROLE AND PLACE OF HYPOGLYCEMIA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
27-32
E.A. Ushkalova
NEW CLASS OF ANTIDIABETIC DRUGS - SODIUM- GLUCOSE COTRANSPORTER INHIBITORS
33-36
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2
BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE
37-41
M.B. Antsiferov 1; V.S. Pronin 2; T.M. Alekseeva 1, L.G. Dorofeeva 1
EXPERIENCE OF MAINTENANCE OF MOSCOW REGISTER OF PATIENTS WITH ACROMEGALY: POTENTIALS FOR THE SOLUTION OF VARIOUS THERAPEUTIC PROBLEMS
42-47
M.B. Antsiferov
LONG-TERM SAFETY AND EFFICACY OF INSULIN ASPART IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
48-51
M.E. Statsenko, M.V. Derevyanchenko
FEATURES OF MANAGEMENT OF HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A VIEW OF CARDIOLOGIST
52-57
E.V. Biryukova, T.B. Danilova
PHARMACOTHERAPY OF DIABETIC NEUROPATHY: WHAT ELSE EXCEPT GLYCEMIC CONTROL?
58-63
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
64-70
A.S. Ametov, E.A. Tertychnaya
MANAGEMENT OF LIPOTOXICITY IN THE DEBUT OF TYPE 2 DIABETES MELLITUS
72-77
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS
78-83
N.A. Strebkova
MAIN PRINCIPLES OF TREATMENT OF DIABETES INSIPIDUS IN CHILDREN
84-87
L.N. Gorobets
GENERAL ISSUES OF DIAGNOSIS AND PREVENTION OF NEUROENDOCRINE DYSFUNCTIONS IN PSYCHIATRIC PATIENTS
88-91
Yu.E. Poteshkin
THE CASE OF PSEUDOHYPOPARATHYREOSIS IN 33 YEAR-OLD MAN
92-95
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.